In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Actigen Ltd.

Division of Affitech AS

Latest From Actigen Ltd.

The Norway Loophole

Cambridge Antibody Technology has built a business based on an exclusive license to a key biotech patent on antibody expression libraries. But the patent holder, Medical Research Council, neglected to file for a patent in Norway. Enter Affitech, which has taken advantage of the loophole to obtain a patent on a more efficient way of creating and screening phage-derived antibody libraries and in the process creating new competition for CAT. Although Affitech can't sell the antibodies it screens outside of Norway, it claims it can legally sell optimized, already screened antibodies to anyone who wants them. And it believes it has an eager customer base.
BioPharmaceutical Europe

Actinova Ltd.

Actinova Ltd. is developing antibacterial therapies and vaccines by building on knowledge of bacterial surface proteins inherited from Lund University, Sweden.
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Norway
  • Parent & Subsidiaries
  • Affitech AS
  • Senior Management
  • Contact Info
  • Actigen Ltd.
    Phone: (47) 22 95 88 77
    Gaustadalléen 21
    Oslo, N-0349